Clinical Characteristics, Natural History, Health Care Measures, and Genetic Screening in Patients With ALS
- Conditions
- Motor Neuron Disease, Amyotrophic Lateral Sclerosis
- Registration Number
- NCT05852405
- Lead Sponsor
- Ambulanzpartner Soziotechnologie APST GmbH
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 2000
Inclusion Criteria:<br><br> - ALS, including classical ALS, Progressive Muscle atrophy (PMA) or Primary Lateral<br> Sclerosis (PLS)<br><br> - Ability to understand the purpose and risks of the study and provide signed and<br> dated informed consent and authorization to use protected health information (PHI)<br> under national and local subject privacy regulations<br><br> - Age of 18 years old at the time of informed consent<br><br>Exclusion Criteria:<br><br> - Inability to provide patient directives about the notification of individual study<br> results on genetic variants of SOD1, C9orf72, FUS and TARDBP<br><br> - Inability to comply with study requirements<br><br> - Unspecified reasons that, in the opinion of the site investigator, perceive the<br> subject as unsuitable for enrollment
Not provided
Study & Design
- Study Type
- Observational [Patient Registry]
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Genetic variants in the genes of SOD1, C9orf72, FUS and TARDBP
- Secondary Outcome Measures
Name Time Method